NLS PHARMACEUTICS LTD (NLSP)
CH0523961370 - Common Stock
NLS PHARMACEUTICS LTD
NASDAQ:NLSP (11/4/2024, 10:29:51 PM)
After market: 3.92 -0.47 (-10.71%)4.39
+0.79 (+21.94%)
Company Profile
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 3 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
Company Info
NLS PHARMACEUTICS LTD
The Circle 6
Zurich ZUERICH CH-6370
P: 41445122150
CEO: Alexander Zwyer
Employees: 7
Website: https://nlspharma.com/
NLSP News
17 hours ago - ChartmillThese stocks are moving in today's pre-market sessionStay updated with the stocks that are on the move in Monday's pre-market session.
8 days ago - ACCESSWIRENLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements21 days ago - ACCESSWIRENLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rulesa month ago - ACCESSWIRENLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayPre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
3 months ago - InvestorPlaceTivic Health Systems (TIVC) Stock Pops Another 39%Tivic Health Systems stock is up on Monday with heavy trading of TIVC shares as recent volatility continues for the company's units.
NLSP Twits
Here you can normally see the latest stock twits on NLSP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
